Skip to main content
AmigoFish

Preventing Relapse: The Role of LAIs in Schizophrenia

From Psychopharmacology and Psychiatry Updates · · 7 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

In this episode, we explore when and why long-acting injectable antipsychotics (LAIs) should be considered for patients with schizophrenia, covering approved indications, ideal candidate profiles, and the critical role of shared decision-making in treatment planning.

Faculty: Brian Miller, M.D., Ph.D., M.P.H. Host: Richard Seeber, M.D.

- Learn more about our memberships here

- Earn 0.75 CME: Use of Long-Acting Injectable Antipsychotics in Schizophrenia

- Understanding When to Prescribe LAIs

Back to Psychopharmacology and Psychiatry Updates · Report a problem